Events

Monday, April 8, 2024

Miller Amphitheatre & Lobby
2nd Floor, Juravinski Innovation Tower
St. Joseph's Healthcare Hamilton (50 Charlton Ave. E., Hamilton)

Reception: 5:30pm
Lecture: 6:15pm

The Department of Medicine and the Divisions of Respirology and Allergy & Clinical Immunology are pleased to announce the 8th Frederick E. Hargreave Lectureship in Asthma and Allergy to honour the memory of our dear colleague, who passed away on the 15th of June, 2011. Professor Freddy Hargreave was one of the giants of respiratory medicine. His work helped change the way we understand, diagnose and treat asthma, bronchitis and COPD. In doing so, he significantly improved the care of patients throughout the world and his work improved many lives. At the Firestone Clinic, over a 40 year career, he taught many students and fellows from all over the world, many of whom returned home and became internationally recognized in their own right. He made St Joseph’s Hospital and the Firestone Clinic world famous, but more importantly, he cared for individual patients in an exemplary manner with unfailing courtesy, dedication, humility, and kindness. He constantly endeavored to bring the health challenges his patients faced every day to the research community in order to find better ways to improve the quality of their lives.

The 2024 Lecture will be delivered by Professor Alberto Papi. Dr. Papi is Professor of Respiratory Medicine at the University of Ferrara, Italy, and the Director of the Respiratory Unit of the Department of Emergency Medicine, S. Anna University Hospital, Ferrara, Italy. Prof. Papi graduated from the University of Ferrrara, and obtained his doctorate at the University of Parma, before spending 4 years in the UK as a clinical research fellow at the University of Southampton, where he is an honorary clinical lecturer. He is a Fellow of the European Respiratory Society and a member of the GOLD Science Committee. Prof. Papi has made phenomenal contributions to our understanding of the molecular mechanisms and pharmacological modulation of asthma and COPD, particularly related to the pathobiology of virus-induced exacerbations. He has coordinated several seminal studies, and has published more than 500 articles in peer-reviewed journals, many of them in the highest impact medical journals. His research has laid the foundation of our current strategies of combination inhaler therapies in patients with asthma, the triple combination inhalers for COPD, the role of fine particle aerosols and peripheral airway diseases, and most recently the use of vaccination for RSV infections.

Supported by unrestricted grants from Methapharm.